Meena Arunachalam

Florence, 50100, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications

Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies.

Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies.

Journal: The oncologist
Published: September 19, 2025

Trastuzumab Deruxtecan‒Related Interstitial Lung Disease/Pneumonitis: Computed Tomography Imaging Patterns to Guide Diagnosis and Management.

Trastuzumab Deruxtecan‒Related Interstitial Lung Disease/Pneumonitis: Computed Tomography Imaging Patterns to Guide Diagnosis and Management.

Journal: JCO precision oncology
Published: December 07, 2023

Ultrasonic investigation of materials-An avenue for project-based learning.

Ultrasonic investigation of materials-An avenue for project-based learning.

Journal: The Journal of the Acoustical Society of America
Published: April 24, 2022

Clinical Outcomes in Patients with FLT3-ITD-Mutated Relapsed/Refractory Acute Myelogenous Leukemia Undergoing Hematopoietic Stem Cell Transplantation after Quizartinib or Salvage Chemotherapy in the QuANTUM-R Trial.

Clinical Outcomes in Patients with FLT3-ITD-Mutated Relapsed/Refractory Acute Myelogenous Leukemia Undergoing Hematopoietic Stem Cell Transplantation after Quizartinib or Salvage Chemotherapy in the QuANTUM-R Trial.

Journal: Transplantation and cellular therapy
Published: July 31, 2020

A large nodule on the scalp of an Indian female.

A large nodule on the scalp of an Indian female.

Journal: European journal of dermatology : EJD
Published: April 19, 2019

Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial.

Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial.

Journal: The Lancet. Oncology
Published: January 18, 2019

An uncommon cause of acral vesiculo-bullous eruption.

An uncommon cause of acral vesiculo-bullous eruption.

Journal: Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia
Published: May 09, 2015

Confluent lesions on left hip of a young woman.

Confluent lesions on left hip of a young woman.

Journal: Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia
Published: May 09, 2015

Autoimmune thyroid disease in Italian patients with non-segmental vitiligo.

Autoimmune thyroid disease in Italian patients with non-segmental vitiligo.

Journal: European journal of dermatology : EJD
Published: December 03, 2014

Correlation of Serum Thyroid Hormones Autoantibodies with Self-Reported Exposure to Thyroid Disruptors in a Group of Nonsegmental Vitiligo Patients.

Correlation of Serum Thyroid Hormones Autoantibodies with Self-Reported Exposure to Thyroid Disruptors in a Group of Nonsegmental Vitiligo Patients.

Journal: Archives of environmental contamination and toxicology
Published: September 05, 2014

Nocardia beijingensis outside of Asia.

Nocardia beijingensis outside of Asia.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: September 02, 2014

Molluscum contagiosum in a 12-year-old child - report of a case and review of literature.

Molluscum contagiosum in a 12-year-old child - report of a case and review of literature.

Journal: Journal of international oral health : JIOH
Published: August 20, 2014
Showing 1-12 of 54

Last Updated: 09/26/2026